Is EVH or FIVN more profitable?

Five9 has a net margin of 4.87% compared to Evolent Health's net margin of -26.29%. Five9's return on equity of 12.66% beat Evolent Health's return on equity. Company Net Margins Return on Equity Return on Assets Evolent Health -26.29% 0.36% 0.10% Five9 4.87% 12.66% 5.52%

Which has stronger earnings & valuation, EVH or NVRI?

Enviri has higher revenue and earnings than Evolent Health. Enviri is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Evolent Health $1.88B 0.24 -$534.51M -$4.76 N/A Enviri $2.24B 0.77 -$167.60M -$2.08 N/A

Is EVH or NVRI more profitable?

Enviri has a net margin of -7.50% compared to Evolent Health's net margin of -26.29%. Evolent Health's return on equity of 0.36% beat Enviri's return on equity. Company Net Margins Return on Equity Return on Assets Evolent Health -26.29% 0.36% 0.10% Enviri -7.50% -8.59% -1.09%

Which has stronger earnings & valuation, STGW or EVH?

Stagwell has higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Stagwell, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Stagwell $2.91B 0.60 $29.10M $0.07 100.79 Evolent Health $1.88B 0.24 -$534.51M -$4.76 N/A

Evolent Health (EVH) Competitors

$4.08 +0.18 (+4.56%)

As of 02:51 PM Eastern

Compare

EVH vs. PAYO, FIVN, NVRI, CNXC, and STGW

Should you buy Evolent Health stock or one of its competitors? MarketBeat compares Evolent Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Evolent Health include Payoneer Global (PAYO), Five9 (FIVN), Enviri (NVRI), Concentrix (CNXC), and Stagwell (STGW). These companies are all part of the "business services" industry.

How does Evolent Health compare to Payoneer Global?

Evolent Health (NYSE:EVH) and Payoneer Global (NASDAQ:PAYO) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.

Evolent Health currently has a consensus price target of $6.00, indicating a potential upside of 47.13%. Payoneer Global has a consensus price target of $7.17, indicating a potential upside of 37.95%. Given Evolent Health's stronger consensus rating and higher probable upside, research analysts clearly believe Evolent Health is more favorable than Payoneer Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	1 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.71
Payoneer Global	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

Evolent Health has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, Payoneer Global has a beta of 1.01, meaning that its share price is 1% more volatile than the broader market.

Payoneer Global has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Payoneer Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.88B	0.24	-$534.51M	-$4.76	N/A
Payoneer Global	$1.05B	1.65	$73.19M	$0.20	25.98

Payoneer Global has a net margin of 6.76% compared to Evolent Health's net margin of -26.29%. Payoneer Global's return on equity of 11.10% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-26.29%	0.36%	0.10%
Payoneer Global	6.76%	11.10%	0.95%

In the previous week, Payoneer Global had 2 more articles in the media than Evolent Health. MarketBeat recorded 2 mentions for Payoneer Global and 0 mentions for Evolent Health. Payoneer Global's average media sentiment score of 0.63 beat Evolent Health's score of 0.00 indicating that Payoneer Global is being referred to more favorably in the news media.

Company	Overall Sentiment
Evolent Health	Neutral
Payoneer Global	Positive

82.2% of Payoneer Global shares are held by institutional investors. 1.5% of Evolent Health shares are held by company insiders. Comparatively, 2.6% of Payoneer Global shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Payoneer Global beats Evolent Health on 12 of the 16 factors compared between the two stocks.

How does Evolent Health compare to Five9?

Evolent Health (NYSE:EVH) and Five9 (NASDAQ:FIVN) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation and profitability.

96.6% of Five9 shares are held by institutional investors. 1.5% of Evolent Health shares are held by insiders. Comparatively, 1.2% of Five9 shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Evolent Health presently has a consensus target price of $6.00, indicating a potential upside of 47.13%. Five9 has a consensus target price of $26.53, indicating a potential upside of 8.68%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts clearly believe Evolent Health is more favorable than Five9.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	1 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.71
Five9	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63

Five9 has a net margin of 4.87% compared to Evolent Health's net margin of -26.29%. Five9's return on equity of 12.66% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-26.29%	0.36%	0.10%
Five9	4.87%	12.66%	5.52%

In the previous week, Five9 had 3 more articles in the media than Evolent Health. MarketBeat recorded 3 mentions for Five9 and 0 mentions for Evolent Health. Five9's average media sentiment score of 0.63 beat Evolent Health's score of 0.00 indicating that Five9 is being referred to more favorably in the news media.

Company	Overall Sentiment
Evolent Health	Neutral
Five9	Positive

Evolent Health has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market. Comparatively, Five9 has a beta of 1.32, indicating that its share price is 32% more volatile than the broader market.

Five9 has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Five9, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.88B	0.24	-$534.51M	-$4.76	N/A
Five9	$1.17B	1.59	$39.42M	$0.66	36.99

Summary

Five9 beats Evolent Health on 12 of the 17 factors compared between the two stocks.

How does Evolent Health compare to Enviri?

Evolent Health (NYSE:EVH) and Enviri (NYSE:NVRI) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability.

Evolent Health currently has a consensus target price of $6.00, suggesting a potential upside of 47.13%. Enviri has a consensus target price of $22.25, suggesting a potential upside of 7.04%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts plainly believe Evolent Health is more favorable than Enviri.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	1 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.71
Enviri	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Enviri has a net margin of -7.50% compared to Evolent Health's net margin of -26.29%. Evolent Health's return on equity of 0.36% beat Enviri's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-26.29%	0.36%	0.10%
Enviri	-7.50%	-8.59%	-1.09%

In the previous week, Enviri had 3 more articles in the media than Evolent Health. MarketBeat recorded 3 mentions for Enviri and 0 mentions for Evolent Health. Enviri's average media sentiment score of 0.60 beat Evolent Health's score of 0.00 indicating that Enviri is being referred to more favorably in the news media.

Company	Overall Sentiment
Evolent Health	Neutral
Enviri	Positive

93.4% of Enviri shares are owned by institutional investors. 1.5% of Evolent Health shares are owned by insiders. Comparatively, 2.5% of Enviri shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Enviri has higher revenue and earnings than Evolent Health. Enviri is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.88B	0.24	-$534.51M	-$4.76	N/A
Enviri	$2.24B	0.77	-$167.60M	-$2.08	N/A

Evolent Health has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market. Comparatively, Enviri has a beta of 1.59, indicating that its stock price is 59% more volatile than the broader market.

Summary

Enviri beats Evolent Health on 10 of the 16 factors compared between the two stocks.

How does Evolent Health compare to Concentrix?

Evolent Health (NYSE:EVH) and Concentrix (NASDAQ:CNXC) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations.

Evolent Health has higher earnings, but lower revenue than Concentrix. Concentrix is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.88B	0.24	-$534.51M	-$4.76	N/A
Concentrix	$9.83B	0.17	-$1.28B	-$21.55	N/A

Evolent Health has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, Concentrix has a beta of 0.37, suggesting that its share price is 63% less volatile than the broader market.

Evolent Health presently has a consensus price target of $6.00, indicating a potential upside of 47.13%. Concentrix has a consensus price target of $48.50, indicating a potential upside of 75.38%. Given Concentrix's higher possible upside, analysts clearly believe Concentrix is more favorable than Evolent Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	1 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.71
Concentrix	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

90.3% of Concentrix shares are owned by institutional investors. 1.5% of Evolent Health shares are owned by company insiders. Comparatively, 0.9% of Concentrix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Concentrix has a net margin of -13.35% compared to Evolent Health's net margin of -26.29%. Concentrix's return on equity of 17.80% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-26.29%	0.36%	0.10%
Concentrix	-13.35%	17.80%	5.45%

In the previous week, Concentrix had 3 more articles in the media than Evolent Health. MarketBeat recorded 3 mentions for Concentrix and 0 mentions for Evolent Health. Concentrix's average media sentiment score of 1.32 beat Evolent Health's score of 0.00 indicating that Concentrix is being referred to more favorably in the news media.

Company	Overall Sentiment
Evolent Health	Neutral
Concentrix	Positive

Summary

Evolent Health and Concentrix tied by winning 8 of the 16 factors compared between the two stocks.

How does Evolent Health compare to Stagwell?

Stagwell (NASDAQ:STGW) and Evolent Health (NYSE:EVH) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership.

Stagwell has a net margin of 0.64% compared to Evolent Health's net margin of -26.29%. Stagwell's return on equity of 24.12% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stagwell	0.64%	24.12%	4.31%
Evolent Health	-26.29%	0.36%	0.10%

In the previous week, Stagwell had 7 more articles in the media than Evolent Health. MarketBeat recorded 7 mentions for Stagwell and 0 mentions for Evolent Health. Stagwell's average media sentiment score of 0.76 beat Evolent Health's score of 0.00 indicating that Stagwell is being referred to more favorably in the media.

Company	Overall Sentiment
Stagwell	Positive
Evolent Health	Neutral

Stagwell has higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Stagwell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stagwell	$2.91B	0.60	$29.10M	$0.07	100.79
Evolent Health	$1.88B	0.24	-$534.51M	-$4.76	N/A

35.6% of Stagwell shares are owned by institutional investors. 11.2% of Stagwell shares are owned by company insiders. Comparatively, 1.5% of Evolent Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Stagwell currently has a consensus target price of $7.65, suggesting a potential upside of 8.43%. Evolent Health has a consensus target price of $6.00, suggesting a potential upside of 47.13%. Given Evolent Health's stronger consensus rating and higher possible upside, analysts plainly believe Evolent Health is more favorable than Stagwell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stagwell	2 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.29
Evolent Health	1 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.71

Stagwell has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, Evolent Health has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market.

Summary

Stagwell beats Evolent Health on 13 of the 16 factors compared between the two stocks.

Get Evolent Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EVH vs. The Competition

Export

Metric	Evolent Health	INTERNET SOFTWARE Industry	Computer Sector	NYSE Exchange
Market Cap	$460.61M	$17.76B	$40.17B	$23.16B
Dividend Yield	N/A	2.93%	3.18%	4.07%
P/E Ratio	-0.86	62.34	79.84	30.85
Price / Sales	0.24	46.58	623.33	24.58
Price / Cash	0.79	66.52	48.68	24.96
Price / Book	1.16	9.75	10.69	4.80
Net Income	-$534.51M	$383.77M	$1.06B	$1.07B
7 Day Performance	3.37%	6.69%	3.54%	1.34%
1 Month Performance	8.03%	11.74%	12.29%	3.05%
1 Year Performance	-44.33%	-1.77%	169.53%	27.31%

Evolent Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EVH Evolent Health	2.3142 of 5 stars	$4.08 +4.6%	$6.00 +47.1%	-49.1%	$460.61M	$1.88B	N/A	4,200
PAYO Payoneer Global	4.8946 of 5 stars	$4.94 -1.2%	$7.17 +45.1%	-25.1%	$1.67B	$1.05B	24.70	2,540
FIVN Five9	4.1118 of 5 stars	$22.76 +4.2%	$26.53 +16.6%	-15.8%	$1.67B	$1.15B	34.49	2,910	Gap Up
NVRI Enviri	1.2768 of 5 stars	$19.60 -1.2%	$22.25 +13.5%	+159.7%	$1.64B	$2.24B	N/A	12,000	Dividend Announcement High Trading Volume
CNXC Concentrix	4.8939 of 5 stars	$26.34 +1.8%	$48.50 +84.1%	-53.6%	$1.58B	$9.83B	N/A	455,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:EVH) was last updated on 5/29/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Evolent Health (EVH) Competitors

EVH vs. PAYO, FIVN, NVRI, CNXC, and STGW

How does Evolent Health compare to Payoneer Global?

Summary

How does Evolent Health compare to Five9?

Summary

How does Evolent Health compare to Enviri?

Summary

How does Evolent Health compare to Concentrix?

Summary

How does Evolent Health compare to Stagwell?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVH vs. The Competition

Evolent Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Evolent Health (EVH) Competitors

EVH vs. PAYO, FIVN, NVRI, CNXC, and STGW

How does Evolent Health compare to Payoneer Global?

Do analysts rate EVH or PAYO?

Which has more volatility and risk, EVH or PAYO?

Which has stronger earnings and valuation, EVH or PAYO?

Is EVH or PAYO more profitable?

Does the media refer more to EVH or PAYO?

Do institutionals & insiders believe in EVH or PAYO?

Summary

How does Evolent Health compare to Five9?

Do insiders & institutionals believe in EVH or FIVN?

Do analysts rate EVH or FIVN?

Is EVH or FIVN more profitable?

Does the media refer more to EVH or FIVN?

Which has more volatility & risk, EVH or FIVN?

Which has better valuation and earnings, EVH or FIVN?

Summary

How does Evolent Health compare to Enviri?

Do analysts prefer EVH or NVRI?

Is EVH or NVRI more profitable?

Does the media refer more to EVH or NVRI?

Do institutionals and insiders have more ownership in EVH or NVRI?

Which has stronger earnings & valuation, EVH or NVRI?

Which has more risk & volatility, EVH or NVRI?

Summary

How does Evolent Health compare to Concentrix?

Which has stronger earnings & valuation, EVH or CNXC?

Which has more risk and volatility, EVH or CNXC?

Do analysts recommend EVH or CNXC?

Do insiders and institutionals believe in EVH or CNXC?

Is EVH or CNXC more profitable?

Does the media favor EVH or CNXC?

Summary

How does Evolent Health compare to Stagwell?

Is STGW or EVH more profitable?

Does the media prefer STGW or EVH?

Which has stronger earnings & valuation, STGW or EVH?

Do insiders & institutionals hold more shares of STGW or EVH?

Do analysts recommend STGW or EVH?

Which has more risk & volatility, STGW or EVH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVH vs. The Competition

Evolent Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools